The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Combined TLR and CD40 Triggering Induces Potent CD8+ T Cell Expansion with Variable Dependence on Type I IFN
Open accessAbstract
Toll-like receptors are important in the activation of innate immunity, and CD40 is a molecule critical for many T and B cell responses. Whereas agonists for either pathway have been used as vaccine adjuvants, we show that a combination of Toll-like receptor (TLR)7 and CD40 agonists synergize to stimulate CD8+ T cell responses 10–20-fold greater than the use of either agonist alone. Antigen-specific CD8+ T cells elicited from combination CD40/TLR7 treatment demonstrated both lytic activities and interferon (IFN)γ production and an enhanced secondary response to antigenic challenge. Agonists for TLRs 2/6, 3, 4, and 9 also synergized with CD40 stimulation, demonstrating that synergy with the CD40 pathway is a property of TLR-derived stimuli in general. The CD8+ T cell expansion induced by CD40/TLR7 triggering was independent of CD4+ T cells, IFNγ, and IL-12 but dependent on B7-mediated costimulation and surprisingly on type I IFN. These studies provide the rational basis for the use of TLR and CD40 agonists together as essential adjuvants to optimize vaccines designed to elicit protective or therapeutic immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. (1997) · Nature · doi:10.1038/41131 · Cited by 5,590
Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80119-3 · Cited by 3,362
Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,822
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Nature · doi:10.1038/31002 · Cited by 2,615
Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway
Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T., Tomizawa, H., Takeda, K., & Akira, S. (2002) · Nature Immunology · doi:10.1038/ni758 · Cited by 2,522
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, J. P., Di Rosa, F., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,342
Help for cytotoxic-T-cell responses is mediated by CD40 signalling
Bennett, S. R. M., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F. A. P., & Heath, W. R. (1998) · Nature · doi:10.1038/30996 · Cited by 2,092
Unresponsiveness of MyD88-Deficient Mice to Endotoxin
Kawai, T., Adachi, O., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80086-2 · Cited by 2,076
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041
Activation of human dendritic cells through CD40 cross-linking.
Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I., & Banchereau, J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1263 · Cited by 1,317
Moskophidis, D., Lechner, F., Pircher, H., & Zinkernagel, R. M. (1993) · Nature · doi:10.1038/362758a0 · Cited by 1,240
Takeuchi, O., Hoshino, K., & Akira, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5392 · Cited by 1,048
Visualizing the generation of memory CD4 T cells in the whole body
Reinhardt, R. L., Khoruts, A., Merica, R., Zell, T., & Jenkins, M. K. (2001) · Nature · doi:10.1038/35065111 · Cited by 1,026 · cited 1×
“This has been is seen in other experimental systems (41, 45, 46) and is probably due to the rapid clearance of the antigen by the high frequency of functional memory cells.”
ResultEssential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4
Yamamoto, M., Sato, S., Hemmi, H., Sanjo, H., Uematsu, S., Kaisho, T., Hoshino, K., Takeuchi, O., Kobayashi, M., Fujita, T., et al. (2002) · Nature · doi:10.1038/nature01182 · Cited by 994
Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo
Kearney, E. R., Pape, K. A., Loh, D. Y., & Jenkins, M. K. (1994) · Immunity · doi:10.1016/1074-7613(94)90084-1 · Cited by 946
Sousa, C. R. E., Hieny, S., Scharton-Kersten, T., Jankovic, D., Charest, H., Germain, R. N., & Sher, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.11.1819 · Cited by 911
IRF3 Mediates a TLR3/TLR4-Specific Antiviral Gene Program
Doyle, S. E., Vaidya, S. A., O'Connell, R., Dadgostar, H., Dempsey, P. W., Wu, T.-T., Rao, G., Sun, R., Haberland, M. E., Modlin, R. L., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00390-4 · Cited by 844
Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848
Jurk, M., Heil, F., Vollmer, J., Schetter, C., Krieg, A. M., Wagner, H., Lipford, G., & Bauer, S. (2002) · Nature Immunology · doi:10.1038/ni0602-499 · Cited by 838
Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon
Le Bon, A., Etchart, N., Rossmann, C., Ashton, M., Hou, S., Gewert, D., Borrow, P., & Tough, D. F. (2003) · Nature Immunology · doi:10.1038/ni978 · Cited by 818
Aruffo, A., Farrington, M., Hollenbaugh, D., Li, X., Milatovich, A., Nonoyama, S., Bajorath, J., Grosmaire, L. S., Stenkamp, R., Neubauer, M., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90668-g · Cited by 814
Self-citationThe adaptor molecule TIRAP provides signalling specificity for Toll-like receptors
Horng, T., Barton, G. M., Flavell, R. A., & Medzhitov, R. (2002) · Nature · doi:10.1038/nature01180 · Cited by 809
TLR4, but not TLR2, mediates IFN-β–induced STAT1α/β-dependent gene expression in macrophages
Toshchakov, V., Jones, B. W., Perera, P.-Y., Thomas, K., Cody, M. J., Zhang, S., Williams, B. R. G., Major, J., Hamilton, T. A., Fenton, M. J., et al. (2002) · Nature Immunology · doi:10.1038/ni774 · Cited by 803
A Role for CD40 Expression on CD8 + T Cells in the Generation of CD8 + T Cell Memory
Bourgeois, C., Rocha, B., & Tanchot, C. (2002) · Science · doi:10.1126/science.1072615 · Cited by 640
Akira, S. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00013-4 · Cited by 584
Alderson, M. R., Armitage, R. J., Tough, T. W., Strockbine, L., Fanslow, W. C., & Spriggs, M. K. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.669 · Cited by 578
Schulz, O., Edwards, A. D., Schito, M., Aliberti, J., Manickasingham, S., Sher, A., & Reis e Sousa, C. (2000) · Immunity · doi:10.1016/s1074-7613(00)00045-5 · Cited by 561
Humoral immune responses in CD40 ligand-deficient mice.
Renshaw, B. R., Fanslow, W. C., Armitage, R. J., Campbell, K. A., Liggitt, D., Wright, B., Davison, B. L., & Maliszewski, C. R. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1889 · Cited by 536
Croft, M., Bradley, L. M., & Swain, S. L. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.6.2675 · Cited by 496
Diehl, L., den Boer, A. T., Schoenberger, S. P., van der Voort, E. I. H., Schumacher, T. N. M., Melief, C. J. M., Offringa, R., & Toes, R. E. M. (1999) · Nature Medicine · doi:10.1038/10495 · Cited by 469
Ito, T., Amakawa, R., Kaisho, T., Hemmi, H., Tajima, K., Uehira, K., Ozaki, Y., Tomizawa, H., Akira, S., & Fukuhara, S. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020207 · Cited by 466
Cutting Edge: Rapid In Vivo Killing by Memory CD8 T Cells
Barber, D. L., Wherry, E. J., & Ahmed, R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.27 · Cited by 443
Alexopoulou, L., Thomas, V., Schnare, M., Lobet, Y., Anguita, J., Schoen, R. T., Medzhitov, R., Fikrig, E., & Flavell, R. A. (2002) · Nature Medicine · doi:10.1038/nm732 · Cited by 435
Sotomayor, E. M., Borrello, I., Tubb, E., Rattis, F.-M., Bien, H., Lu, Z., Fein, S., Schoenberger, S., & Levitsky, H. I. (1999) · Nature Medicine · doi:10.1038/10503 · Cited by 407
T Cells Compete for Access to Antigen-Bearing Antigen-Presenting Cells
Kedl, R. M., Rees, W. A., Hildeman, D. A., Schaefer, B., Mitchell, T., Kappler, J., & Marrack, P. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1105 · Cited by 406
Self-citationGibson, S. J., Lindh, J. M., Riter, T. R., Gleason, R. M., Rogers, L. M., Fuller, A. E., Oesterich, J. L., Gorden, K. B., Qiu, X., McKane, S. W., et al. (2002) · Cellular Immunology · doi:10.1016/s0008-8749(02)00517-8 · Cited by 375
Self-citationShrikant, P., Khoruts, A., & Mescher, M. F. (1999) · Immunity · doi:10.1016/s1074-7613(00)80123-5 · Cited by 283
Differential activation requirements for virgin and memory T cells.
Byrne, J. A., Butler, J. L., & Cooper, M. D. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.10.3249 · Cited by 268
Cytokine induction by the immunomodulators imiquimod and S-27609
Testerman, T. L., Gerster, J. F., Imbertson, L. M., Reiter, M. J., Miller, R. L., Gibson, S. J., Wagner, T. L., & Tomai, M. A. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.58.3.365 · Cited by 265
Resting Memory CD8+ T Cells are Hyperreactive to Antigenic Challenge In Vitro
Pihlgren, M., Dubois, P. M., Tomkowiak, M., Sjögren, T., & Marvel, J. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2141 · Cited by 239
CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency.
Farrington, M., Grosmaire, L. S., Nonoyama, S., Fischer, S. H., Hollenbaugh, D., Ledbetter, J. A., Noelle, R. J., Aruffo, A., & Ochs, H. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.3.1099 · Cited by 227
Self-citationColes, R. M., Mueller, S. N., Heath, W. R., Carbone, F. R., & Brooks, A. G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.834 · Cited by 224
Hernandez, J., Aung, S., Redmond, W. L., & Sherman, L. A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.707 · Cited by 217
Dubey, C., Croft, M., & Swain, S. L. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3280 · Cited by 196
Pape, K. A., Merica, R., Mondino, A., Khoruts, A., & Jenkins, M. K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4719 · Cited by 193
Schmidt, C. S., & Mescher, M. F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2561 · Cited by 135
Ahonen, C. L., Gibson, S. J., Smith, R. M., Pederson, L. K., Lindh, J. M., Tomai, M. A., & Vasilakos, J. P. (1999) · Cellular Immunology · doi:10.1006/cimm.1999.1555 · Cited by 131
Self-citationMauri, C., Mars, L. T., & Londei, M. (2000) · Nature Medicine · doi:10.1038/76251 · Cited by 120
Cho, H. J., Hayashi, T., Datta, S. K., Takabayashi, K., Uden, J. H. V., Horner, A. A., Corr, M., & Raz, E. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.4907 · Cited by 111
Short-circuiting long-lived humoral immunity by the heightened engagement of CD40
Erickson, L. D., Durell, B. G., Vogel, L. A., O’Connor, B. P., Cascalho, M., Yasui, T., Kikutani, H., & Noelle, R. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14110 · Cited by 107
Self-citationDoxsee, C. L., Riter, T. R., Reiter, M. J., Gibson, S. J., Vasilakos, J. P., & Kedl, R. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1156 · Cited by 102
Self-citationSoluble Antigen and CD40 Triggering Are Sufficient to Induce Primary and Memory Cytotoxic T Cells
Lefrançois, L., Altman, J. D., Williams, K., & Olson, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.725 · Cited by 101
Kedl, R. M., & Mescher, M. F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.674 · Cited by 100
Self-citationCutting Edge: Rapid In Vivo CTL Activity by Polyoma Virus-Specific Effector and Memory CD8+ T Cells
Byers, A. M., Kemball, C. C., Moser, J. M., & Lukacher, A. E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.17 · Cited by 100
Lee, B. O., Hartson, L., & Randall, T. D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031440 · Cited by 93
Molecular Mechanisms of B Lymphocyte Activation by the Immune Response Modifier R-848
Bishop, G. A., Hsing, Y., Hostager, B. S., Jalukar, S. V., Ramirez, L. M., & Tomai, M. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5552 · Cited by 84
Maxwell, J. R., Campbell, J. D., Kim, C. H., & Vella, A. T. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2024 · Cited by 82
Kedl, R. M., Jordan, M. B., Potter, T. A., Kappler, J. W., Marrack, P., & DOW, S. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191371898 · Cited by 80
Self-citationAntigen‐presenting Cells for CD8+ T Cells
Sprent, J., & Schaefer, M. E. (1990) · Immunological Reviews · doi:10.1111/j.1600-065x.1990.tb00574.x · Cited by 56
Karaca, K., SHARMA, J. M., Tomai, M. A., & Miller, R. L. (1996) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1996.16.327 · Cited by 34
Cited by
IRF-7 is the master regulator of type-I interferon-dependent immune responses
Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., et al. (2005) · Nature · doi:10.1038/nature03464 · Cited by 2,245
Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines
Melief, C. J. M., & van der Burg, S. H. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2373 · Cited by 594
VISTA Regulates the Development of Protective Antitumor Immunity
Le Mercier, I., Chen, W., Lines, J. L., Day, M., Li, J., Sergent, P., Noelle, R. J., & Wang, L. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1506 · Cited by 486
Self-citationHailemichael, Y., Dai, Z., Jaffarzad, N., Ye, Y., Medina, M. A., Huang, X.-F., Dorta-Estremera, S. M., Greeley, N. R., Nitti, G., Peng, W., et al. (2013) · Nature Medicine · doi:10.1038/nm.3105 · Cited by 457
Nancy, P., Tagliani, E., Tay, C.-S., Asp, P., Levy, D. E., & Erlebacher, A. (2012) · Science · doi:10.1126/science.1220030 · Cited by 429
Metadata
- Authors
- Ahonen, C. L., Doxsee, C. L., McGurran, S. M., Riter, T. R., Wade, W. F., Barth, R. J., Vasilakos, J. P., Noelle, R. J., & Kedl, R. M.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2004-03-08
- Volume
- 199
- Issue
- 6
- Pages
- 775-784
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2131811425
- Cited by
- 362
- References
- 59
- FWCI
- 8.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.